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Background: According to Cobanoglu et al., it is now widely acknowledged that the single target paradigm
(one protein/target, one disease, one drug) that has been the dominant premise in drug development in the
recent past is untenable. More often than not, a drug-like compound (ligand) can be promiscuous – it can interact with
more than one target protein.
In recent years, in in silico target prediction methods the promiscuity issue has generally been approached
computationally in three main ways: ligand-based methods; target-protein-based methods; and integrative
schemes. In this study we confine attention to ligand-based target prediction machine learning approaches,
commonly referred to as target-fishing.
The target-fishing approaches that are currently ubiquitous in cheminformatics literature can be essentially viewed as
single-label multi-classification schemes; these approaches inherently bank on the single target paradigm assumption
that a ligand can zero in on one single target. In order to address the ligand promiscuity issue, one might be able to
cast target-fishing as a multi-label multi-class classification problem. For illustrative and comparison purposes,
single-label and multi-label Naïve Bayes classification models (denoted here by SMM and MMM, respectively) for
target-fishing were implemented. The models were constructed and tested on 65,587 compounds/ligands and
308 targets retrieved from the ChEMBL17 database.
Results: On classifying 3,332 test multi-label (promiscuous) compounds, SMM and MMM performed differently.
At the 0.05 significance level, a Wilcoxon signed rank test performed on the paired target predictions yielded by
SMM and MMM for the test ligands gave a p-value < 5.1 × 10−94 and test statistics value of 6.8 × 105, in favour of
MMM. The two models performed differently when tested on four datasets comprising single-label (non-promiscuous)
compounds; McNemar’s test yielded χ2 values of 15.657, 16.500 and 16.405 (with corresponding p-values of
7.594 × 10−05, 4.865 × 10−05 and 5.115 × 10−05), respectively, for three test sets, in favour of MMM. The models
performed similarly on the fourth set.
Conclusions: The target prediction results obtained in this study indicate that multi-label multi-class approaches
are more apt than the ubiquitous single-label multi-class schemes when it comes to the application of ligand-based
classifiers to target-fishing.
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It is now widely acknowledged that the single target
paradigm (i.e. one protein/target, one disease, one drug)
that has been the dominant premise in drug develop-
ment in recent past is untenable as both drug-like com-
pound (ligand) and target protein can be promiscuous
[1, 2]. More often than not, a ligand can simultaneously
interact with multiple proteins in a human cell; this ob-
servation can also be true with target proteins [2, 3]. For
example, according to Mestres [4], there is on average
6–7 annotated targets per drug in DrugBank [5]. It is,
therefore, important that ligand (and protein) promiscu-
ity is taken into consideration when developing in silico
target protein prediction models. In this regard, signifi-
cant efforts have been made in recent years in taking
into account the promiscuity issue when devising in
silico target protein prediction models [1–3, 6–9] (and
references there in). The state-of-the-art methods that
consider ligand (and protein) promiscuity when pre-
dicting target proteins can be broadly divided into three
categories namely ligand-based [1, 3, 6, 7, 10, 11],
target-structure-based [1, 3, 6, 8], and ligand-target-pair-
based [1, 3, 6, 9]. In this study we confine attention to
ligand-based machine learning approaches, commonly
referred to as target-fishing.
The central idea that constitutes the nub of the ligand-
based machine learning approach is that a new ligand
sharing enough structural similarity to a set of reference
ligands annotated against known target proteins has a
high probability of showing activity against the prede-
fined target proteins [6] (and references therein).
The target-fishing approach began to appear in the
cheminformatics literature over the last decade and a
half [10–21]. According to Rognan [6], the target-fishing
methods all share three basic components: (a) a set of
reference ligands represented in a descriptor/feature
space are selected; (b) a screening procedure, such as a
machine learning algorithm (for example, Bayesian clas-
sification scheme, which is the focus of the present
work), is devised; and (c) the screening procedure deter-
mines whether a new compound is likely to share the
same target protein as the reference ligands. In short, all
this means: using a given activity dataset comprising a
set of reference ligands, a set of target proteins and a bi-
partite activity relation between the targets and ligands
in the two sets, a model is constructed such that for a
new ligand the model returns the appropriate targets
against which this ligand shows activity – we will come
back to this and describe it in more concrete terms.
As far as we are aware, at the time of writing, the
ligand-based machine learning approaches – with few ex-
ceptions (see the Previous work section) – utilised in che-
minformatics explicitly or implicitly assume that the target
proteins against which the reference ligands are annotatedare mutually exclusive [3, 6, 10, 11, 15, 17, 22–24] (and
references therein). It is assumed a ligand can (somehow)
zero in on one single protein in the midst of the multitude
of proteins in a human cell, which is the very questionable
assumption noted above [1, 2, 4]. In machine learning
(and also in statistics), this type of ligand-based target pre-
dicting approach can be viewed as a single-label multi-
class classification problem, vide infra; this is schematically
illustrated in Fig. 1. In contrast, as in this work, one might
be able to take into account ligand promiscuity by casting
the ligand-based target prediction task/approach as a
multi-label multi-class classification problem. That is, the
relevant target proteins for a certain ligand need not be
mutually exclusive. Figure 1 shows an example of multi-
label multi-class classification problem. The essence of
“multi-label multi-class classification” and “single-label
multi-class classification problem” will be covered and
described in detail later in this section and also in the
Materials and methods section.
In any event, in the light of the discussion in the preced-
ing paragraphs the machine learning ligand-based target
predicting approach (target-fishing) is basically a
ligand-based classification problem [3, 6, 22–25],
whereby a (machine learning) classifier is utilised to pre-
dict potential target protein(s) for a given ligand. Thus, de-
veloping an accurate – computationally efficient and
conceptually appropriate – ligand-based classifier is an im-
portant research topic in cheminformatics. To this end,
the nub of devising an efficient ligand-based classification
model can amount to developing a mathematical algo-
rithm that “learns” the chemical structure-biological ac-
tivity relationships (if any) from a given set of reference
ligand chemical structures, a predefined set of target
proteins and a bipartite activity relation between the
reference ligands and targets. Once the learning phase
of the model/classifier building is completed, for a new
compound the resultant classifier is expected to accur-
ately predict relevant target proteins (in the preselected
set of target proteins) against which this compound
may show biological activity.
The ligand chemical structure is usually represented as
a “vector” (descriptor/feature vector) whose elements,
ideally, constitute the salient characteristics of the ligand
for its interaction with potential target protein(s). There
are a plethora of chemical structure representation
schemes that have been suggested over the years [26, 27].
Simply one cannot predicate that a given representation of
a chemical structure can capture all the subtleties intrinsic
to a particular chemical structure of the ligand, which
might be crucial for the biological effect that a ligand
could induce on the relevant target proteins. Another
source of uncertainty is the certitude that measurements
of observable biological effects (and subsequently data-
bases based on these observations) are inevitably noisy
Fig. 1 Different classification schemes. (a) Single-label binary classification scheme. Purinergic receptor P2Y12 (ChEMBL2001) shown in cyan and
Butyrylcholinesterase (ChEMBL1914) shown in purple illustrate a binary classification problem. In binary classification, only 2 disjoint classes exist.
Therefore in this classification scheme, |L| = 2 and |Y| = 1. (b) Single-label multi-class classification scheme. Phosphodiesterase 10A (ChEMBL4409)
in green has been added to a single-label binary classification problem to form a single-label multi-class classification problem. That is to say, a
single-label multi-class classification has more than two disjoint classes; hence, |L| > 2 (in this case |L| = 3) while |Y| = 1. (c) Multi-label multi-class
classification scheme. Serine/threonine-protein kinase PIM1 (ChEMBL2147) in yellow, Protein kinase C delta (ChEMBL2996) in magenta and c-Jun
N-terminal kinase 1 (ChEMBL2276) showed in grey, illustrate a multi-label multi-class classification. In multi-label classification problem, classes are
not disjoint and compounds can belong to more than 1 class. Here, compounds shown in red belong to all 3 classes and have |Y| > 1 (in this case
|Y| = 3). Furthermore, like the single-label multi-class classification problems, in this multi-label multi-classification scheme the value of |L| is bigger
than 2 as we are dealing with more than two classes.
Afzal et al. Journal of Cheminformatics  (2015) 7:24 Page 3 of 14[28, 29]; this uncertainty can, in turn, introduce another
layer of uncertainty in relating the chemical structure of
the ligand with its observable activity against a target pro-
tein. It is, therefore, desirable to develop a ligand-based
classification approach that takes into account these un-
certainties. This deems a probabilistic classifier a good
candidate for the task [19, 24, 30–37].
In more concrete terms, a ligand-based classifier can
be viewed as an algorithm that appropriately associates
ligand j denoted by a descriptor vector xj with protein
target(s) – often referred to as classes/labels, denoted by
l1,…, lk,…, l|L| – against which xj may show activity.
Henceforth, all the target labels are collectively denoted
as set L = {l1,…, lk,…, l|L|}. Usually xj is viewed as a “vector”
defined on an m-dimensional descriptor space χ, where
xj = {xj1, …, xji,…, xjm}; often the elements xji are as-
sumed to represent the “relevant” chemical structure
descriptors/properties of ligand j in relation to the targets.
In the present work, xji are binary, representing the
absence or presence of a chemical atom environment
descriptors in the ligand.
A tacit assumption that is often made is that one has ac-
cess to a representative dataset, D, that adequately captures
the bipartite activity relation between the target proteins
and reference ligand chemical structures: D = { (xj,Yj)},
j = 1, …, N denoting the N available data points, where
xj ∈ χ is as described before and Yj⊆ L refers to a set of
targets against which xj is known to be active.In the literature [38–45], when |Yj| = 1, a classification
model is referred to as a single-label classifier; but when
|Yj| ≥ 2, the classification model is referred to as a multi-
label classifier. Furthermore, a classification problem can
also be called a binary classification problem if |L| = 2
(see Fig. 1a) and a multi-class classification problem
when |L| > 2 (see Fig. 1b). Thus, a multi-class classification
task can be categorised as a multi-label multi-class classifi-
cation problem as depicted in Fig. 1c or as a single-label
multi-class classification problem, (see Fig. 1b). For an ex-
tended and detailed account of the multi-label multi-class
classification topic the reader may consult refs. [38–45].
Given D, the classification task amounts to “learning”
or estimating a function (if one exists)
f : χ→Ω ð1Þ
which not only correctly associates xj with its known
label(s) Yj , but also predicts the correct label(s) for a
new ligand that is not included in the training dataset,
D. (In the multi-label scenario, Ω is the power set of
set L, whereas in the single-label approach, Ω = L.) In
effect, our main task is to come up with a model that
elucidates or captures the unknown underlying process
that might have generated the observed phenomena,
i.e. the dataset D, in the first place.
In Eq. 1 the function can denote a ligand-based deter-
ministic or probabilistic classifier [30–37]. In the present
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fiers, which are probabilistic. In this case, both xj and Yj
are random variables, but for notational simplicity in this
work lk, Yj and xj denote both the random variables and
the values they may assume. Furthermore, unless stated
otherwise, the index j in xj, Yj and xji and the index k in
lk are omitted for notational clarity.
As discussed in the Previous work section (see below),
to our best knowledge – at the time of writing – the tar-
get-fishing approaches employed in cheminformatics
(with a few exceptions) rely on the assumption that a
given ligand can only interact with one target protein,
i.e., |Y| = 1 [10–13, 15, 17, 22, 23]. In other words,
these ligand-based target predicting methods, prob-
abilistic or not, can be considered as single-label multi-
class classification models [10, 11, 13, 15, 17, 22, 23]. In
these methods a single-label multi-class classification
model can be |L| induced binary (one–vs–all) classifiers
[10, 12, 15], or just a single conventional multi-class
classifier [11, 13, 17, 22, 23]. In this work we employed
the latter classifiers (for our single-label multi-class
classification problems), as they are more apt than the
one–vs–all classifiers [23]. In any event, the high prob-
ability of a ligand interacting with more than one target
protein – that is, |Y| ≥ 2 – in nature [1–4, 46–51] can
render the single-label classification approach question-
able as a target-fishing scheme.
In the light of our earlier discussion, when |Y| ≥ 2
(and, of course, |L| > 2), one may consider a ligand-
based target prediction problem as a multi-label multi-
class classification task. Since target proteins/classes are
not necessarily mutually exclusive in the case of |Y| ≥ 2,
a lone multi-label multi-class ligand-based model can, in
principle, capture the underlying association (if any)
between the chemical structure of a ligand and the set
of labels Y⊆ L denoting potential target proteins for
the ligand. However, this principled approach is prac-
tically infeasible in our context. Nonetheless, there is
nothing in principle to prevent one from approximating
the ideal model by devising |L| induced binary classi-
fiers that can associate a given ligand with its set of
potential target proteins – providing that the available
training set D is appropriately transformed (for a de-
tailed account of training set transformation in the
multi-label classification context, see ref. [39]). It is
important to note that there are subtle, but crucial dif-
ferences between the “conventional” induced binary
classifiers (i.e., one-vs-all type classifiers) employed in
single-label ligand-based models described earlier and
the induced binary classifiers – that we have just de-
scribed –henceforth referred to as “pseudo single-
label” binary classifiers. This subtle issue is briefly
commented on in the Methods section, but for a more
detailed description, see ref. [38].In our multi-label multi-class classification approach,
|L| “pseudo single-label” binary classifiers were con-
structed, whereby the data transformation scheme utilised
was binary relevance [39].
Classification approaches based upon Naïve Bayes
markedly feature in the probabilistic classification
models for target-fishing [10, 12, 13, 15, 19] (and refer-
ences therein). For this reason, we concentrated on this
particularly popular ligand-based classification model.
The popularity of the Naïve-Bayes as a target-fishing tool
can be probably attributed to the fact that building non-
Naïve Bayes multi-class classifiers (be probabilistic or
not) can become conceptually intricate or computation-
ally demanding, or both [10, 11, 17–19, 22–24, 33–37].
The Naïve Bayes approach is: (1) probabilistic; (2)
favourably scalable with m, |L|, and N, where m, |L| and
N are as defined before; (3) computationally simple to
implement; and (4) known to yield respectable classifica-
tion results, despite the flimsiness of the rationale upon
which the algorithm is based – that is, descriptors for a
ligand are conditionally independent of each other
given the class label. It is these characteristics that give
the application of Naïve Bayes based target-fishing ap-
proaches an edge over other classification algorithms also
employed for this purpose [19] (and references therein).
Previous work
For more recent developments on target-fishing ap-
proaches, we refer the reader to refs. [1, 3] and [6]. To our
knowledge, there were no research papers, at the time of
writing, regarding the topic of comparing single-label and
multi-label multi-class Naïve Bayes classifications for
target-fishing. Michielan et al. [20] employed multi-
label multi-class classification to classify cytochrome
p450 substrates. The authors employed multi-label
multi-class classification models based on SVM, MLK-
Nearest-Neighbour, and Neural Network on a dataset
of 580 cytochrome p450 substrates and seven isoforms.
Hristozov et al. [21], also employing SVM, Neural Net-
work, and MLK-Nearest-Neighbour methods [42], looked
into classifying sesquiterpene lactones into seven tribes
from the plant family Asteraceae. The two research groups
compared the performance of single-label and multi-label
models, and cautiously noted that multi-class classifiers
based on the multi-label concept outperformed, or per-
formed just as well as their corresponding single-label
multi-class classifiers. However, their work did not feature
the subject matter here: Naïve Bayes algorithms; besides,
compared to ours their studies covered only seven targets.
Wale and Karypis employed multi-label ligand-based clas-
sification methods [16]. Unlike our study, the the main
thrust of Wale and Karypis’s work was about comparing
how different multi-label ligand-based classifiers perform
on classifying multi-label bioactivity datasets. Similarly
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the performance of a multi-label ligand-based SVM
classifier; the single-label aspect did not feature in their
work, nor did single-label and multi-label Naïve Bayes
algorithms.
Closely following studies in text mining [52], we im-
plemented and studied a ligand-based Naïve Bayes
multi-label multi-class classification model (MMM) for
target-fishing. We compared this classifier with a single-
label multi-class ligand-based Naïve Bayes classification
model (SMM) designed for the same purpose. Both clas-
sification models were built and tested on a bioactivity
dataset extracted from the ChEMBL17 database [53],
which was comprised of 308 protein target classes and
65,587 compounds.
In the following and preceding sections the words “lig-
and” and “compound” are used interchangeably. Also the
terms “class”, “activity”, “label”, “target” and “target protein”
are employed interchangeably. A single-label compound
means that a compound is active against only one target,
while a multi-label compound refers to a compound that is
active against more than one target. A single-label dataset
refers to a dataset containing only single-label compounds,
whereas a multi-label dataset refers to a dataset comprising
multi-label (i.e., promiscuous) compounds.
Materials and methods
Dataset
In order to construct and validate our MMM and SMM
classification models, we used the ChEMBL17 database,
which comprises more than 1 million annotated com-
pounds and more than 10 million bioactivity records cov-
ering 9,000 targets. The dataset used for this study was a
subset of ChEMBL17, which consisted of 65,587 unique
compounds covering 308 human targets giving a total of
93,281 ligand-target pairs. Structures with reported activ-
ities (IC50/ki/kd/EC50) equal or better than 1 μM and
confidence scores of 8 or 9 against human protein targets
were selected. The confidence score represents the assay-
to-target relationship in the ChEMBL database. It indi-
cates the type of target assigned to a particular assay as
well as the confidence that assigned target is the correct
target for the assay. The range of the confidence score is
from 0 to 9, where 0 represents uncurated data and 9 re-
fers to a single protein target that has been assigned to the
assay with high degree of confidence.Table 1 Distribution of the compounds and their associated protein
Number of Annotated Targets 1 2 3 4
Number of Compounds 54,563 7,937 1,571 3
% of Total Number of Compounds 83.1 % 12.1 % 2.39 % 0
The table shows that 83.1 % of the total compounds were annotated against only o
against two or more protein targets; just over one-sixth of our ChEMBL17 dataset cAlthough this bioactivity value represented highly po-
tent compounds, given the increase in the size of
ChEMBL17 database, it represented a sensible trade-off
between biological activity and coverage of the chem-
ical space. Only protein classes that contained between
120 and 720 data points were selected to ensure that
the dataset was balanced.
Table 1 summarises our ChEMBL17 dataset D. Al-
though, as it can be seen in the table, the majority of the
compounds in the dataset were single-label compounds,
there were a significant number of multi-label com-
pounds (more than one-sixth of the total number of
compounds) in our dataset. Hence, we believe, this was
a suitable dataset for testing the hypothesis described in
the Background section – that is, the multi-label multi-
class approaches are more apt than the ubiquitous
single-label multi-class schemes when it comes to the
application of ligand-based classifiers to target-fishing.
Table 2 and Fig. 2a depict the distribution of target pro-
teins in different protein families. The majority of target
proteins are categorised as enzymes and membrane recep-
tors, with enzymes representing 67.8 % of all the protein
targets/classes in our ChEMBL17 dataset, and membrane
receptors constituting 23 % of it. Figure 2b depicts the dis-
tributions of the enzyme classes. A significant proportion
of the enzyme families in our dataset consisted of the Kin-
ase and Protease classes, with 54 % and 15 %, respectively.
7TM1 receptors constitute the bulk (89 %) of all the mem-
brane receptor classes in our dataset (see Fig. 2c).
A table showing the full list of ChEMBL IDs of targets
and compounds per class is given as Additional file 1.
Train and test sets
Our ChEMBL17 dataset was randomly split into two por-
tions: 70 % of it as a training set and the remaining 30 % as
a test set.
Multi-label and single-label training set
The training set consisted of 45,911 compounds and their
labels, whereby some of the compounds had more than
one label. This set, which contained both single-label and
multi-label compounds, was utilised to construct the
multi-label multi-class model (MMM). The single-label
multi-class model (SMM) was built on a single-label data-
set, which was generated from the 45,911 compounds and
their labels by simply associating each compound withtargets in our ChEMBL17 dataset
5 6 7 8 9 ≥10
21 240 191 132 60 42 530
.49 % 0.36 % 0.29 % 0.2 % 0.09 % 0.06 % 0.8 %
ne target protein, while the remaining 16.9 % of compounds were annotated
omprises multi-label ligands
Table 2 Distribution of target proteins in different protein families in our ChEMBL17 dataset
Enzyme membrane receptor transcription factor ion channel Transporter cytosolic other Unclassified secreted
Number of Classes 209 71 7 4 7 8 1 1
% of Total Classes 67.85 % 23.05 % 2.27 % 1.29 % 2.27 % 2.59 % 0.32 % 0.32 %
90.8 % of the protein targets are enzymes and membrane receptors, with enzymes representing 67.8 % of all the protein targets, and membrane receptors
constituting 23 %
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against more than one target, the highest measured bio-
activity (for the compound) was retained.
Multi-label and single-label test set
The remaining 30 % of our ChEMBL17 dataset contained
19,676 test compounds. Among these, 16,344 compounds
were single-label while 3,332 compounds were multi-label.
This gave us two sets of test datasets: A single-label
test set comprising 16,344 single-label compounds,
and a multi-label test set consisting of 3,332 multi-
label compounds.
The asymmetric abundance of the Kinase, Protease and
7TM1 classes in the dataset (see Table 2 and Fig. 2) allows
us to generate three more datasets out of the original
single-label test dataset (henceforth referred to as the
“Global dataset”): one dataset comprising of Kinases; a
dataset containing only Proteases and a 7TM1 dataset.
This in turn allowed us to validate the two classificationFig. 2 Protein target distribution in the ChEMBL17 dataset. (a) Protein targ
(b) The distribution of protein targets in enzyme families. (c) The distributiomodels (SMM and MMM) further, and more comprehen-
sively scrutinise our hypothesis proposed in this work.
In passing, we only partitioned the original single-label
test dataset into subsets because the number of single-
label test compounds were not only 5 times (or more)
larger than the number of multi-label test compounds
contained in the multi-label test, but were also well dis-
tributed over the 308 target proteins constituting our
predefined set of class labels.
Compound descriptors
Compounds were standardized prior to fingerprint gener-
ation by ChemAxon’s Standardizer [54] using the options
“Remove Fragments”, “Neutralize”, “Remove Explicit
Hydrogen” and “Tautomerize”. Extended Connectivity
Fingerprints (ECFP) were employed to describe com-
pound structures [55–58]. ChemAxon’s Java API [54] was
utilized to generate fixed-length ECFP_4 binary finger-
prints with a length of 1,024 bits.et distribution among protein families in the ChEMBL17 dataset.
n of protein targets in membrane receptor families.
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In this section we briefly describe the single-label and
multi-label multi-class Naïve Bayes algorithms that were
employed in this study.
Naïve Bayes
According to the Naïve Bayes assumption, the descrip-
tors {x1 , . . . , xm} constituting the elements of the
descriptor vector x representing the ligand are as-
sumed independent given the class label l [19]. In this
setting, a choice of f (in Eq. 1) can be the class pos-
terior probability p(l | x), where p(l | x) can be
expressed as [19]
p ljxð Þ ¼
Ym
i¼1p xi j lð Þ P lð Þ
p xð Þ ð2Þ
where P(l) refers to the probability of the class label l.
This term represents one’s state of knowledge about the
class label before obtaining the data for the ligands. The
term p(xi | l) denotes the conditional probability for xi
given l, and p(x) is as defined below; m is as described
before. In this study, xi is binary – i.e., xi ∈ {0, 1}. Com-
paratively, it is a simple affair to estimate P(l). Thus, in
practice, estimating p(l|x) reduces to the estimation ofYm
i¼1p xi j lð Þ, i.e. the p(xi | l)’s.
Single-label Multi-class Naïve Bayes (SMM)
In the single-label multi-class Naïve Bayes model (SMM)
employed in this work, where |Y| = 1 and |L| > 2, p(x)
was expressed as p xð Þ ¼
XLj j
l¼1
Ym
i¼1
p xi j lð Þ P lð Þ.
The class conditional probability p(xi | l) was esti-
mated as
p xi jlð Þ ¼ 1þ n
þ
il
2þ nl ð3Þ
where nþil denotes the number of times that the ith de-
scriptor xi assumes the value 1 in class l and nl is the
number of instances in the training set belonging to
class l. Here, p(xi |l) was estimated using the Laplacian
correction [19]. The prior distribution of each class P(l)
was computed as
P lð Þ ¼ nl
N
ð4Þ
where N denotes the total number of single-label train-
ing data points.
One classifier was built for each target protein l using
Eqs. 2, 3, 4 and the compounds in the single-label
training, which were annotated against this target pro-
tein only. For predicting potential target proteins for a
new compound, SMM outputs |L| class/target posteriorprobability values – one for each class. The new com-
pound is assigned to the class with the highest poster-
ior probability value.
Multi-label multi-class naïve Bayes (MMM)
The multi-label multi-class Naïve Bayes model (MMM),
with |Y| ≥ 2 and |L| > 2, was implemented based on Wei
et al. [52], where a binary relevance transformation [39]
was utilised. However, any other appropriate transform-
ation of the training set could have been employed [39].
Wei et al.’s approach is briefly described below for com-
pleteness. For a detailed account and more erudite de-
scription of what transforming the training set entails in
the multi-label context, the reader is referred to ref. [39].
Using Eqs. 2, 3, 4 and a binary relevance transform-
ation, |L| “pseudo single-label” binary classifiers, Hl : χ→
{l, ¬ l}, were constructed – one for each unique label l
in the set L. (The term “pseudo single-label” is as de-
fined and described in the Background section and in
the paragraph below.) In order to construct the |L|
“pseudo single-label” binary classifiers, the original train-
ing dataset D was transformed into |L| datasets Dl,
where each Dl contains all the instances in D. Each com-
pound in Dl is labelled active if it is labelled l and other-
wise labelled inactive by the class label ¬ l.
If all the compounds in the training dataset are single-
label compounds, then a “pseudo single-label” binary
classifier, Hl : χ→ {l, ¬ l}, is nothing more than a one-vs-
all binary classifier. However, in the ligand-based target
predicting approach (target-fishing), a ligand needs not
be a single-label compound. This means the binary clas-
sifier, Hl : χ→ {l, ¬ l}, generated in our multi-label multi-
class classification is not strictly a one-vs-all single-label
classifier – hence, the attribute “pseudo single-label”.
Obviously, one might more aptly call our Hl : χ→ {l, ¬ l}
a “pseudo one-vs-all” binary classifier. The reader is re-
ferred to ref. [38, 39, 52] for more details on this topic.
To predict the appropriate class labels (potential target
proteins) for a new test compound x, the multi-label
multi-class classification scheme – based on the “pseudo
single-label” binary approach described earlier – outputs
the union of the labels predicted by the |L| classifiers, Z:
Z ¼∪
l ∈L
l : Hl xð Þ≥ pthresholdf g ð5Þ
where Hl(x) denotes p(l|x) for compound x. Here
p(l|x) was computed via Eq. 2, where p(x) and p(l)
were given by p xð Þ ¼
Ym
i¼1
p xi j lð Þ P lð Þ þ
Ym
i¼1
p xi j¬lð Þ P
¬lð Þ and p lð Þ ¼ nlN , whereas p ¬lð Þ ¼ 1− nlN , and p(xi | l)
and p(xi | ¬ l) were estimated by using Eq. 3 - mutatis
mutandis.
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pthreshold (see Model construction and testing section).
Model evaluation schemes
We employed two evaluation schemes namely a “Recall–
Precision” metric, and a scheme based on ranking the
class posterior probability estimates for the test compound
labels. The “Recall–Precision” metric was employed to
evaluate MMM and SMM performances on classifying
single-label test compounds. The ranking evaluation
metric was utilised to assess MMM and SMM perfor-
mances on classifying multi-label test compounds.
“Recall–Precision” metric: evaluating MMM and SMM
performance on single-label data
In the multi-label multi-class classification scenario, a
class prediction made by a multi-label multi-class model
(MMM) can be fully correct, partially correct or fully
wrong. Hence, the evaluation schemes for MMM are
more complicated than those employed for evaluating
the generalisation ability of a single-label multi-class
model (SMM), whose prediction can only be fully cor-
rect or fully wrong.
For MMM, recall and precision evaluation measures
based on ref. [44] are widely employed in the machine
learning literature; we followed suit:
precision ¼ 1
Tj j
XTj j
t¼1
Y t∩Ztj j
Ztj j ð6Þ
recall ¼ 1
Tj j
XTj j
t¼1
Y t∩Ztj j
Y tj j ð7Þ
where T denotes the multi-label test set which has |T|
examples (xt, Yt), t = 1,…, |T|; Yt (⊆L) denoting the set
of labels to which xt belongs; and Zt ¼∪
l ∈L
l : Hl xtð Þ≥ pthresholdf g represents the set of labels to
which xt is predicted to belong.
However, in the case of SMM, recall and precision
values are computed (per class) as
precision ¼ TP
TP þ FP ð8Þ
recall ¼ TP
TP þ FN ð9Þ
where “TP” denotes the number of compounds that the
model assigns to their actual target, (say) target A; “FN”
refers to the number of compounds annotated against
target A, but assigned to other targets, whereas “FP”
represents the number of compounds whose associated
target was wrongly predicted to be target A.Evaluating the generalization ability of SMM (using
Eqs. 8 and 9) on classifying single-label compounds is
straightforward. However, the same cannot be said about
MMM because in this case the classification predictions
can be partially correct, fully correct or fully wrong.
Thus, to make the comparison of the classification per-
formance of the two models (MMM and SMM) on the
single-label dataset at hand as equitable as possible, only
the predicted class label in the top position (i.e., with the
largest class posterior probability value) of the predicted
set of class labels Zt for xt is considered as the predicted
class label when computing |Yt ∩ Zt| in Eqs. 6 and 7.
This means the so-called rejection option/ threshold
value was not taken into consideration. (In both MMM
and SMM, a class prediction resulting in a tie – two or
more classes are equally predicted – is arbitrarily
assigned to one class.)
It should be noted that, while the “Recall-Precision”
metric described above puts the “recalls” in Eq. 7 and
Eq. 9 on equal footings, it heavily penalises the precision
value in the MMM case as the denominators in Eqs. 6
and 8 indicate.
In passing, a comparison of the two models (SMM
and MMM) utilising single-label datasets may seem to
be vacuous. However, we point out that this is not ne-
cessarily the case: As described in the Multi-label
multi-class naïve Bayes section, our MMM is not a
mere combination of |L| single-label binary classifiers,
each being a one-vs-all binary classifier trained on a
single-label dataset that ignores possible overlaps
among the target proteins at the outset. Furthermore, a
single-label test dataset does not necessarily imply that
each compound in the set is conclusively single-label.
Even if it were, MMM, which is more powerful/com-
plex than SMM by design, could still have a better
chance (than SMM) of correctly identifying the protein
against which the test ligand is supposed to be active.
However, MMM is also equally more likely to yield
false positives than SMM will.
The ranking metric: evaluating MMM and SMM
performance on multi-label data
The ranking metric utilised in this work evaluates
MMM and SMM performance (on classifying multi-
label compounds) equitably. This evaluation scheme
works as follows:
For a given a test ligand xt
a) Using Eq. 5 with pthreshold being set to zero, MMM
computes |Zt| class posterior probability estimates.
(Note that |Zt| = |L| when pthreshold = 0.) These |L|
posterior probability values computed are then
ranked in descending order, such that the class/
labels with the largest class posterior probability
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the class/label with the second largest class posterior
probability value is placed in rank position 2; and so
on.
b) Similarly, SMM computes |L| class posterior
probability values that are also ranked in descending
order, whereby the class/label with the largest class
posterior probability value obtained is defined to be
in rank position 1; the class/label with the second
largest class posterior probability value is placed in
rank position 2; and so on.
c) If the test ligand xt is known to be active against |Yt|
targets (that is, the ligand is annotated against |Yt|
labels), the rank positions of these labels in the |L|
rank positions described in (a) (see above) are
accordingly paired with their corresponding rank
positions in the |L| rank positions yielded by SMM,
described in (b). This results in |Yt| paired label/
target rank positions for the test compound xt.
d) (a), (b) and (c) are repeated for each test ligand. This
yields M paired class label rank positions, whereby
M ¼
X Tj j
t¼1 Y tj j, with |T| denoting the number of
test data points (see the preceding section).
e) The Wilcoxon signed rank test is utilised to test
whether the two M label rank positions – returned
by MMM and SMM for the |T| test ligands – are
statistically different.Model construction and testing
Our ChEMBL17 dataset D was randomly split into two
portions – 70 % of it as a training set, and the remaining
30 % as a test set.
Using the 70 % ChEMBL17 dataset allotted to training,
the multi-label multi-class classification and single-label
multi-class classification models based on the Naïve
Bayes concept were generated, see Methods.
The multi-label multi-class classification model
(MMM) was built on the whole training set – i.e., con-
taining both single-label and multi-label compounds.
The single-label multi-class classification model (SMM)
was built only on single-label training set, which was
generated from the multi-label training set by simply as-
sociating each compound with only one of its targets,
whereby the target with the highest measured bioactivity
was retained.
To compare the classification performance of the
MMM and SMM (on the remaining 30 % of our
ChEMBL17 dataset) we utilised the two evaluation
schemes described in the previous section: the “Recall–
Precision” metric and the ranking scheme. In the SMM
there was no parameter to estimate to compute Eqs. 8
and 9. However, in the MMM, the “optimal” value of the
pthreshold value (see Eq. 5) had to be estimated tocompute Eqs. 6 and 7. This was achieved via 5-fold cross
validation on the single-label training set. For all the re-
sults given in the following section the MMM algorithm
performed best when pthreshold was set to 0.999.
Figure 3 summarises the workflow of this study and
datasets used to test the hypothesis.
Results and discussion
In the following analyses, in the first four subsections the
test sets were comprised of single-label compounds, while
in the fifth subsection the test set consisted of multi-label
compounds. It is worthy of note that the class predictions
(and the subsequent analyses) presented in this study were
retrospective in the sense that the predicted targets were
known beforehand.
Classification performance on single-label test set
The two classification models, MMM and SMM, were
tested on predicting the appropriate targets for the four
single-label datasets: Global set; 7TM1 set; Kinases set;
and Proteases set.
Global test set
MMM and SMM were tested on predicting the appropri-
ate targets for 16,344 single-label test compounds distrib-
uted over 308 target proteins. Columns 2 and 3 in Table 3
demonstrate the target prediction performance of the two
models for the single-label compounds in the global test
set: SMM returned recall and precision values of 0.7805
and 0.7596 (Column 2), respectively; the corresponding
recall and precision values yielded by MMM were 0.8058
and 0.6622 (Column 3), respectively. Figure 4a depicts the
bar plots of the two sets of recall and precision figures in
Columns 2 and 3 of Table 3.
7TM1 test set
The test set consisted of 4,403 compounds distributed
over 63 7TM1 proteins.
For this test set, SMM returned recall and precision
values of 0.8176 and 0.8783 (Column 2: Table 4), respect-
ively. The corresponding recall and precision values given
by MMM were 0.8008 and 0.7002 (Column 3: Table 4),
respectively. Figure 4b depicts the bar plots of these re-
call and precision pair values.
Kinase test set
The dataset comprised 2,887 compounds annotated
against 63 Kinases. For this test set, SMM gave recall
and precision values of 0.6726 and 0.6741, (Column 4:
Table 4), respectively; for the test set MMM yielded re-
call and precision values of 0.7797 and 0.5080 (Column
5: Table 4), respectively. The bar plots of the recall and
precision pair values are shown in Fig. 4c.
Fig. 3 Workflow and datasets of the study. The workflow of this study and datasets used to test the hypothesis. Multi-label dataset, model (MMM) and
evaluation procedures are shown in blue and single-label dataset, model (SMM) and evaluation steps are shown in green. The ChEMBL 17
dataset consists of single-label and multi-label compounds. This dataset was randomly split into 2 portions: 70 % as a training set and 30 % as
a test set. The MMM was trained on the available training set whereas the SMM was trained only on single-label training set. This single-label
training set was extracted from the multi-label training set by simply assuming that each compound belongs to only one target. Out of
19,676 test set compounds, 16,344 test compounds were single-label and 3,332 test compounds were multi-label. Hence, single-label test data
set was built from 16,344 single-label test compounds while multi-label test set was built from 3,332 multi-label test compounds. SMM and
MMM were tested on both single-label and multi-label test sets. To evaluate the performance of SMM and MMM models on single-label test
set “Recall-Precision” and McNemar’s test were employed. On the multi-label test set, ranking scheme was utilised to compare the generalisation ability
of the two models
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Here, the test set contained 1,927 compounds distrib-
uted over 31 Proteases.
For this test set, SMM yielded recall and precision
values of 0.8376 and 0.8666 (Column 6: Table 4), respect-
ively; and their corresponding recall and precision
values obtained by MMM were 0.8474 and 0.6325
(Column 7: Table 4), respectively. Similarly Fig. 4d
demonstrates the bar plots of these recall and preci-
sion pair values.
The recall figures reported for the Global, Proteases and
Kinase test sets indicate that MMM returned better recall
values than SMM. Only for the 7TM1 test set, the MMM
classifier returned a recall value worse than the recallTable 3 Recall and precision values returned by MMM and
SMM on predicting the target proteins for single-label compounds
in the global test set
Test Compounds Single-label Compounds
Models SMM MMM
Recall 0.7805 0.8058
Precision 0.7596 0.6622value yielded by the SMM classifier. However, SMM sys-
tematically gave better precision values compared to the
precision values returned by MMM. These better preci-
sion values returned by SMM could be explained as an
artefact due to the “Recall – Precision” evaluation metric
employed: as described in the Method section, this evalu-
ation scheme heavily penalises (see the denominators in
Eqs. 6 and 8) the precision value returned by MMM.
Another possible explanation for the reason why SMM
returned better (worse) recall (precision) values than
those values obtained by MMM was that SMM and
MMM were different in nature: SMM model wasTable 4 Recall and precision returned by MMM and SMM on
predicting the target proteins for single-label test compounds
annotated against single proteins in the 7TM1, Kinase and
Protease protein families
Compounds Single label compounds
Protein Family 7TM1 Kinase Protease
Models SMM MMM SMM MMM SMM MMM
Recall 0.8176 0.8008 0.6726 0.7797 0.8376 0.8474
Precision 0.8783 0.7002 0.6741 0.5080 0.8666 0.6325
Fig. 4 MMM and SMMM target prediction performance on test sets. (a) Bar plots of the recall and precision values shown in columns 2 and 3 in
Table 3, the performances of the MMM and SMM models for 16,344 single-label ChEMBL17 test compounds covering 308 target proteins. (b) Bar
plots depict the recall and precision values (Columns 2 and 3 in Table 4) that illustrate the performance of both models for 4,403 single-label
ChEMBL17 test compounds covering 63 7TM1 target proteins. (c) Bar plots represent the recall and precision values (Columns 4 and 5 in Table 4)
returned by the two classification models for 2,887 single-label ChEMBL17 test compounds covering 89 Kinase target proteins. (d) Bar plots
denote the recall and precision values (Columns 6 and 7 in Table 4), the target prediction performance of the models for 1,927 single-label
ChEMBL17 test compounds covering 31 Protease target proteins
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evaluation schemes section.
Further analysis of the single-label classification re-
sults revealed that MMM either statistically outper-
formed (or performed equally well as) SMM. For
example, we statistically compared the number of
single-label test compounds whose class labels were
correctly predicted by MMM, but not SMM to the
number of test compounds whose class labels were cor-
rectly predicted by SMM, but not MMM. McNemar's
test [59] on these paired classification (and misclassifi-
cation) results returned by the two models for the Glo-
bal, 7TM1, and Proteases datasets yielded χ2 values of
15.657, 16.500 and 16.405 (with corresponding p-values
of 7.5 x 10−05, 4.8 x 10−05 and 5.5 x 10−05), respectively –
in favour of MMM. For the Kinases test set, the χ2 value
was 2.485 (p-value of 0.1), which meant that MMM and
the SMM performed similarly on this test set. Here and in
the rest of the paper, the phrase “in favour of MMM”
indicates that the number of test compounds whoselabels were incorrectly predicted by the MMM, but not
SMM < the number of test compounds whose labels
were wrongly predicted by the SMM, but not MMM
(see Additional file 2).
Performance on multi-label test set
MMM and SMM algorithms were tested on predicting
potential target proteins for 3,332 multi-label com-
pounds, whereby each test compound xt was known to
be annotated against two or more target proteins (la-
bels), but no more than 57 labels – i.e., |Yt| ∈ [2, 57].
This means each model was tested on predicting/iden-
tifying
XTj j¼3;332
t¼1
Y tj j ¼ 5; 656 labels. The prediction per-
formance of the two models was then compared by
using the ranking metric scheme fully described in Sec-
tion “The ranking metric: evaluating MMM and SMM
performance on multi-label data”. This resulted in
5,656 paired label rank positions.
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were similar for 3,336 labels. However, for the remaining
2,320 labels, models predicted different rank positions. For
886 labels (out of the 2,320 labels), SMM gave higher rank
positions for the correct labels than MMM did, whereas
MMM yielded better label rank positions for the other
1,434 labels. This is clearly depicted by the histogram
in Fig. 5. Furthermore, at a 0.05 significance level, a
Wilcoxon signed rank test performed on the 5,656
paired label rank positions gave a p-value < 5.1 × 10−94
(test statistics of 6.8 × 105), which indicates that the two
models performed differently with respect to the multi-
label test dataset employed.
All these analyses suggest that MMM statistically gener-
alises better than SMM based on the ChEMBL17 dataset
utilised. Thus, one could argue that the target-fishing re-
sults yielded by our multi-label and single-label models
certainly – albeit statistically – lend support to the argu-
ment against the single-target paradigm and target-fishing
methods that are based on this paradigm.
Conclusion
In this work two in silico ligand-based target prediction
models – single-label multi-class and multi-label multi-
class Naïve Bayes classifiers – were constructed and
tested on a large dataset of bioactivity data extracted
from the ChEMBL17 database. This dataset was randomly
split into two portions: 70 % as training set and 30 % as
test set. The training set was converted to single-label and
multi-label training sets. The multi-label multi-class classi-
fication model (MMM) was built on multi-label training
set while single-label multi-class classification model
(SMM) on single-label training set. Furthermore, out of
19,676 test compounds, 3,332 compounds were multi-
label (multi-label test set) while 16,344 compounds were
single-label (single-label test set).Fig. 5 Histogram of pairwise differences of the labels predicted for test comp
performances of MMM and SMM algorithms on predicting the 5,656 labels is
position, for a target, predicted by MMM (SMM) is higher than that by SMM (M
same rank position for a target.Statistically, MMM significantly outperformed its cor-
responding SMM on predicting the appropriate target
proteins for 3,332 ChEMBL17 test compounds anno-
tated against two or more (out of 308) target proteins. A
Wilcoxon signed rank test performed on the classifica-
tion results returned by SMM and MMM for the test set
gave a p-value < 5.1 × 10−94 (test statistics of 6.8 × 105),
which indicated that the two models performed differ-
ently based on the dataset employed.
When tested on four (Global, 7TM1, Proteases and
Kinases) datasets, each comprising ChEMBL17 only
single-label test compounds, the MMM also statistically
outperformed the SMM on three out of the four data-
sets. McNemar's test on paired MMM and SMM classi-
fication results for the global, 7TM1, and Proteases
datasets yielded χ2 values of 15.657, 16.500, and 16.405,
respectively (with corresponding p-values of 7.594 x 10−05,
4.865 x 10−05 and 5.115 x 10−05, respectively) – in favour
of the MMM. The χ2 value was 2.485 (with a p-value of
0.115) for the fourth test set (the Kinases test set),
which meant that MMM and SMM performed simi-
larly. When the “Recall-Precision” evaluation metric
was utilised, MMM returned better (worse) recall (pre-
cision) values compared to those values obtained by
SMM (see Table 4).
The target prediction results obtained are in line
with the hypothesis set out within this study, i.e., it is
not appropriate, nor is it adequate to universally em-
ploy single-label multi-class ligand-based classification
approaches for target-fishing. Thus, based on the data-
sets utilised in this work, one may conclude that out
of the two classification approaches (SMM and MMM)
tested, the multi-label multi-class model (MMM) is
robust and more apt (and should be utilised) for ligand-
based target-fishing purposes – the subject matter in this
study.ounds annotated against two or more target proteins. The differences in
shown. On the x-axis, negative (positive) value indicates that the rank
MM). On the x-axis: zero denotes that MMM and SMM returned the
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